NDC 70000-0636-01 - Leader Daytime Severe Cold and Flu Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0636
- Requested NDC
- 70000-0636-01
- Package NDCs from labels
- 70000-0636-1, 70000-0636-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2024-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Leader Daytime Severe Cold and Flu Relief - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2024-11-07 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0636-1 | Leader Daytime Severe Cold and Flu Relief | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 3 | |
| 70000-0636-1 | Leader Daytime Severe Cold and Flu Relief | 12 in 1 CARTON | TABLET, FILM COATED | 12 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0636 | LEADER DAYTIME SEVERE COLD AND FLU RELIEF (ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE) TABLET, FILM COATED [CARDINAL HEALTH 110, LLC. DBA LEADER] | 3 | Current NDC, 2 package rows | 20241109_dd82a389-9ec5-4b3f-a9ea-1a56871ebd17.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | ARMY AND AIR FORCE EXCHANGE SERVICE | f1157dbc-d86c-4554-954c-60a74674ff6b | 2026-11-02 | Warnings | 362O9ITL9D |
| equate pain reliever | ACETAMINOPHEN | WALMART INC. | 59d01f72-4575-48e2-b914-b6a6456ca7d2 | 2026-11-02 | Warnings | 362O9ITL9D |
| Allergy | CHLORPHENIRAMINE MALEATE | Bryant Ranch Prepack | c948e612-a491-4ad0-adb9-cf31ef76e4d8 | 2026-11-02 | Warnings | M012 |
| HERA SILKYSTAY FOUNDATION 34W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f3ef340-c68e-1790-e063-6394a90a44aa | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40c97f-b90e-bec7-e063-6394a90ae5db | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 35N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f40f46b-c6b2-df1f-e063-6394a90afd96 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 37W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4105f3-d08b-edb5-e063-6394a90ad28b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 39N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41120a-521a-f5ac-e063-6394a90ac021 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 41W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4158f0-c743-29c2-e063-6394a90ac721 | 2026-11-01 | Warnings | 15FIX9V2JP |
| Chlo Hist | CHLOPHEDIANOL HYDROCHLORIDE, DEXBROMPHENIRAMINE MALEATE | R. A. McNeil Company | d046f4ba-5753-4ed5-a924-0b66fd116781 | 2026-11-01 | Warnings | M012 |
| Chlo Tuss | CHLOPHEDIANOL HYDROCHLORIDE, DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE | R.A. McNeil Company | 43610aaa-8b94-40d5-ae09-3d75bd2317c8 | 2026-11-01 | Warnings | M012 |
| HERA SILKYSTAY FOUNDATION 43N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f41ecb2-9fe5-ade7-e063-6294a90abc4e | 2026-11-01 | Warnings | 15FIX9V2JP |
| M-END DMX | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | R. A. McNeil Company | ee1fae2e-3a21-4487-9989-c7620a4a7056 | 2026-11-01 | Warnings | M012 9D2RTI9KYH |
| HERA SILKYSTAY FOUNDATION 43O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f425415-ed84-fc33-e063-6394a90a15f7 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 44C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f42d960-6b86-b4cd-e063-6294a90a98f3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4335c8-596f-3269-e063-6294a90a6c3d | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 46W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43404e-bdab-3f4b-e063-6294a90ab881 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 47N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f435148-dcb1-cfdf-e063-6394a90aa8b6 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 50N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43610f-6c4f-dd9d-e063-6394a90ab60a | 2026-11-01 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.